Trividia Health Correction for TRUE METRIX Blood Glucose Monitoring Systems

Trividia Health Correction for TRUE METRIX Blood Glucose Monitoring Systems

HealthTech HotSpot
HealthTech HotSpotMay 1, 2026

Key Takeaways

  • Updated labeling addresses E‑5 error code on TRUE METRIX meters.
  • Patients advised to use alternative testing until software upgrade released.
  • Trividia plans field‑wide meter upgrade program with FDA coordination.
  • Updated product notice distributed to pharmacies, distributors, and end users.
  • Support line 1‑888‑943‑2387 operates Mon‑Fri 8 AM‑8 PM EST.

Pulse Analysis

The TRUE METRIX family—METRIX, AIR, GO, and PRO—has been a staple in home diabetes monitoring for years, but a persistent E‑5 error code raised concerns about delayed detection of extreme glucose values. Trividia’s May correction builds on a February 2026 labeling update, providing clearer instructions directly on meter and test‑strip packaging. By aligning the messaging with FDA expectations, the company aims to mitigate confusion and reduce the risk of missed hypo‑ or hyperglycemic events, a critical safety issue for patients relying on intensive insulin regimens.

For clinicians and patients, the immediate takeaway is heightened vigilance. Those on sulfonylureas or intensive insulin therapy are urged to switch to an alternative testing method until the software fix arrives, minimizing the chance of delayed treatment. Healthcare providers must now counsel patients on the new E‑5 protocol and ensure they have access to the updated product notice. Pharmacies and distributors play a pivotal role by posting the notice at points of sale and forwarding it to end users, reinforcing a coordinated safety net across the supply chain.

From a business perspective, Trividia’s proactive stance demonstrates a commitment to regulatory compliance and brand integrity. The planned field‑wide upgrade, developed in partnership with the FDA, signals a long‑term solution that could restore confidence among retailers and insurers. While the recall may temporarily affect sales, transparent communication and a clear upgrade roadmap are likely to preserve market share and limit reputational damage. The company’s dedicated support line and online resources further underscore its focus on patient safety and operational resilience.

Trividia Health Correction for TRUE METRIX Blood Glucose Monitoring Systems

Comments

Want to join the conversation?